 Connection
James Suen to Immunoenzyme Techniques
This is a "connection" page, showing publications James Suen has written about Immunoenzyme Techniques.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.101 |
|
|
|
-
Kannan A, Lin Z, Shao Q, Zhao S, Fang B, Moreno MA, Vural E, Stack BC, Suen JY, Kannan K, Gao L. Dual mTOR inhibitor MLN0128 suppresses Merkel cell carcinoma (MCC) xenograft tumor growth. Oncotarget. 2016 Feb 09; 7(6):6576-92.
Score: 0.034
-
Hou F, Dai Y, Dornhoffer JR, Suen JY, Fan CY, Saad AG, Buckmiller LM, Richter GT. Expression of endoglin (CD105) and endothelial nitric oxide synthase in head and neck arteriovenous malformations. JAMA Otolaryngol Head Neck Surg. 2013 Mar; 139(3):237-43.
Score: 0.028
-
Dai Y, Hou F, Saad A, Fan CY, Buckmiller LM, Suen JY, Richter GT. Preliminary investigation of human lymphatic malformations in vitro. Laryngoscope. 2011 Nov; 121(11):2435-42.
Score: 0.025
-
Liu K, Zuo C, Luo QK, Suen JY, Hanna E, Fan CY. Promoter hypermethylation and inactivation of hMLH1, a DNA mismatch repair gene, in head and neck squamous cell carcinoma. Diagn Mol Pathol. 2003 Mar; 12(1):50-6.
Score: 0.014
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|